Skip to main content
. 2017;18(3):795–802. doi: 10.22034/APJCP.2017.18.3.795

Figure 1.

Figure 1

Viability of MCF7 (A) and MDA-MB-231 (B) Cells after Treatment with Different Concentrations and Incubation Times of Doxorubicin